GLP‑1 and loose skin after weight loss: why it happens and what helps
Loose skin after GLP‑1 weight loss is common. Learn why it happens and what strategies can help support skin firmness.
Read More →Is compounded semaglutide safe: what you need to know
Compounded semaglutide is not FDA-approved and lacks the same quality controls as brand-name medications. Learn the risks, cost differences, and what changed after the semaglutide shortage ended.
Read More →Best exercises while on GLP‑1 medications: what to do and when
Many GLP‑1 users actually decrease physical activity after starting medication. Here is why exercise matters more, not less, on these drugs and what types deliver the best results.
Read More →GLP‑1 dose schedules explained: titration, maintenance, and what to expect at each level
Compare current labeled starting, escalation, and maintenance doses for injectable and oral GLP‑1 medications, plus when to call your prescriber.
Read More →How to switch between GLP‑1 medications safely
Switching GLP-1 medications requires a prescriber-guided start date and dose. Learn why there is no universal conversion or washout rule and what to track during a transition.
Read More →Lump after a GLP‑1 injection: lipohypertrophy, swelling, or infection
A lump after a GLP‑1 shot can have several causes. Learn how to tell routine swelling from lipohypertrophy or signs that need medical attention.
Read More →GLP‑1 medications and fertility: what women need to know
GLP‑1 medications can restore ovulation in women with PCOS and unexpectedly increase fertility through weight loss. Here is what the research says about conception planning, contraception, and safety.
Read More →GLP‑1 and menstrual changes: what women are reporting about their periods
Women on GLP‑1 medications are reporting heavier periods, irregular cycles, and unexpected fertility changes. A 2026 medRxiv study of 67,008 Reddit users flagged menstrual irregularities as an emerging signal. Here is what we know so far.
Read More →What happens when you stop taking a GLP‑1 medication: the data on weight regain
Research consistently shows that most people regain approximately two-thirds of lost weight within a year of stopping a GLP‑1 medication. Here is what the data says, why it happens, and how to prepare.
Read More →GLP‑1 and constipation: why it happens and how to find relief
Constipation affects roughly 24 percent of people taking semaglutide at its highest dose, and unlike nausea it often persists throughout treatment. Here is why it happens and what actually helps.
Read More →Ozempic vs Wegovy vs Mounjaro vs Zepbound: how to compare GLP‑1 medications
Ozempic, Wegovy, Mounjaro, and Zepbound are the four most prescribed GLP‑1 medications on the market. This guide breaks down their active ingredients, approved uses, clinical trial results, and costs so you can have a more informed conversation with your provider.
Read More →Best foods to eat and avoid on GLP‑1 medications
What you eat on semaglutide or tirzepatide matters more than ever because appetite suppression means every calorie counts. Here are the foods that support your progress and the ones that cause problems.
Read More →What to expect in your first month on a GLP‑1: a week-by-week guide
Starting semaglutide or tirzepatide comes with changes your body needs time to adjust to. Here is what to expect each week and when something needs medical attention.
Read More →Medication leaked after your GLP‑1 injection: did you get the full dose
A small drop after a GLP‑1 shot can be normal, but larger leakage may mean technique needs adjusting. Learn what to check before your next dose.
Read More →How long should you stay on GLP‑1 medications: what the evidence says
Most experts now treat obesity as a chronic condition requiring long-term management. Learn what happens at different treatment durations, why people stop, and how to plan ahead.
Read More →How to manage nausea on GLP‑1 medications: practical relief that works
Nausea is the most common GLP‑1 side effect, but it is also the most manageable. Learn when it peaks, why it happens, and the evidence-based strategies that reduce it.
Read More →